As France 24 marks World Cancer Day, François Picard welcomes Lars Henning Milman Engelholm, Associate Professor and Group Leader at the Finsen Laboratory, Rigshospitalet / Biotech Research & Innovation Centre (BRIC), University of Copenhagen. From his lab in Copenhagen, Professor Engelholm describes a seismic shift underway in pancreatic cancer research, the result of a decade-long commitment to the steady evolution of translational science.[/gpt3]
Universities innovate, Big Pharma develops: Public and philanthropic funding crucial to treat cancer
